Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Tracking Intestinal Dominance by Multi-Drug Resistant Organisms among Paediatric Patients as a Marker for Microbiome Dysbiosis and Extra-Intestinal Spread

PROVIDER: PRJNA911601 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR22729828.fastq.gz	Fastqsanger.gz
	SRR22729829.fastq.gz	Fastqsanger.gz
	SRR22729830.fastq.gz	Fastqsanger.gz
	SRR22729831.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 49

Similar Datasets

Intestinal IL-17R signaling controls liver inflammation by constraining microbiome-induced TLR9 signaling and IL-18 production

Project description:IL-17 and IL-17R signaling in the intestinal epithelium regulate the intestinal microbiome. Given the reported links between intestinal dysbiosis, bacterial translocation, and liver disease, we hypothesized that intestinal IL-17R signaling plays a critical role in mitigating hepatic inflammation. To test this, we studied intestinal epithelial-specific IL-17RA deficient mice in a model of concanavalin A hepatitis. Absence of enteric IL-17RA signaling exacerbated hepatitis and hepatocyte cell death. These mice exhibited commensal dysbiosis, increased intestinal and liver Il18, and increased liver translocation of bacterial products, specifically CpG DNA. Mechanistically, CpG DNA induced hepatic IL-18, increasing IFNγ and FasL in hepatic T-cells to drive inflammation. Thus, intestinal IL-17R regulates translocation of TLR9 ligands and constrains susceptibility to hepatitis. These data connect enteric Th17 signaling and the microbiome in hepatitis, with broader implications on the effects of impaired intestinal immunity and subsequent release of microbial products seen in other extra-intestinal pathologies.

2019-12-10 | GSE128284 | GEO

Proteomic Profiling of Dysbiosis-Challenged Broilers: Blood Biomarkers for Intestinal Health

Project description:The intestinal microbiome forms dynamic ecosystem whose balanced composition and functioning are essential for maintaining overall gut health and well-being in living organisms. In broilers, dysbiosis disrupts the microbiota-host balance, often without obvious clinical symptoms but with intestinal inflammation, leading to impaired animal performance and significant economic losses. This study utilizes an in vivo model of dysbiosis to investigate the blood proteome response of broilers to intestinal imbalance. Microscopic histological changes in the gut (shorter villi, increased crypt depth, p<0.0001) were observed in the duodenal and jejunal tissue of challenged birds. Elevated levels of permeability markers faecal ovotransferrin (p < 0.0001) and serum iohexol (p= 0.0009) additionally indicated increased intestinal permeability in challenged group compared to control. The MS/MS-based proteomics analysis was performed on broilers’ blood plasma enabling identification of 388 proteins, 25 of which demonstrated significant difference between the groups. Functional analysis showed activation of immune response, signalling, and interspecies interaction, while proteins related to cellular physiology, cell-cell communication, and extracellular matrix (ECM) processes were suppressed. Protein-protein interaction (PPI) analysis revealed two clusters of downregulated proteins involved in ECM organization and cell adhesion. These results suggest that the dysbiosis challenge alters plasma protein expression as the host prioritizes immune defense over structural maintenance. The activation of immune processes and suppression of ECM pathways highlight potential biomarkers and therapeutic targets for addressing dysbiosis.

2025-07-14 | PXD056546 | Pride

Mouse liver and kidney proteome with antibiotics treatment

Project description:Dysbiosis (alteration of intestinal flora) is associated with various host physiologies, including diseases. The purpose of this study was to clarify the effect of dysbiosis on protein expression levels in mouse liver and kidney by quantitative proteomic analysis, focusing in particular on drug-metabolizing enzymes and transporters in order to investigate the potential impact of dysbiosis on drug pharmacokinetics.

2018-01-01 | PXD008237 | JPOST Repository

A dynamic atlas of immunocyte migration reveals specific populations of gut-imprinted cells in distal tissues

Project description:Dysbiosis in the gut microbiota impacts several systemic diseases. One possible mechanism is the migration of perturbed intestinal immunocytes to extra-intestinal tissues. Combining the Kaede photoconvertible mouse model and single-cell genomics, we generated a detailed map of migratory trajectories from the colon, at baseline and during intestinal and extra-intestinal inflammation. All colonic lineages emigrated from the colon in an S1P-dependent manner, dominated by B lymphocytes with a large continuous circulation of follicular B cells, which carried a gut-imprinted transcriptomic signature. T cell emigration was more selective, with distinct groups of RORg+ cells and IEL-like CD160+ T cells in the spleen. Gut inflammation curtailed emigration, except for DCs disseminating to lymph nodes. Colon emigrating cells distributed differentially to tumor, skin inflammation, or arthritic synovium, the former dominated by myeloid cells in a chemokine-dependent manner. These results thus reveal specific cellular trails originating in the gut, influenced by microbiota, which can shape peripheral immunity.

2023-09-13 | GSE216928 | GEO

JPST000349-10 Mouse liver and kidney proteome with antibiotics treatment [Reanalysis: JPST000349]

2023-04-01 | RPXD034318 | JPOST Repository

JPST000349-7 Mouse liver and kidney proteome with antibiotics treatment [Reanalysis: JPST000349]

2023-04-01 | RPXD034315 | JPOST Repository

JPST000349-6 Mouse liver and kidney proteome with antibiotics treatment [Reanalysis: JPST000349]

2023-04-01 | RPXD034314 | JPOST Repository

JPST000349-5 Mouse liver and kidney proteome with antibiotics treatment [Reanalysis: JPST000349]

2023-04-01 | RPXD034313 | JPOST Repository

JPST000349-4 Mouse liver and kidney proteome with antibiotics treatment [Reanalysis: JPST000349]

2023-04-01 | RPXD034312 | JPOST Repository

JPST000349-9 Mouse liver and kidney proteome with antibiotics treatment [Reanalysis: JPST000349]